BioVoice News September 2017 Issue 4 Volume 2 | Page 29

Moreover, the factor that should be considered to make cancer treatment accessible in India is giving priority to the proven treatment options at a faster pace. The efforts to lower the cost of treatment and the drugs to make cancer treatment affordable for all classes in India will act as a catalyst to the growth of oncology treatment. Creating awareness to prevention and early detection will be critical to a successful cancer care structure in the country. Affordability and access to the advanced oncology treatment options and drugs are the need of the hour. Government stakeholders along with private healthcare providers and medical organizations should come forward to create better awareness on cancer. Diagnosis if done at the early stage can help combat the disease and can reduce the disease burden both on the doctor as well as the patient. MR PRAVEEN BOSE Mr Praveen Bose is the Senior Vice President and Head of Sales and Marketing at Sayre Therapeutics. In the current role, he is spearheading the entire gamut of sales, marketing and operations for all products and services that is being commercialized in India. Prior to this, Praveen has been working at Biocon, one of Asia’s leading Biotech companies, for a decade and his last assignment was as Senior Director-Head of Oncology and Immunology business – India and SAARC. BIOVOICENEWS.COM 29